http://www.nytimes.com/2006/09/22/business/22generic.html?_r=1&oref=sloginRelief for Some but Maybe Not Many in Wal-Mart Plan for $4 Generic Drugs
By MICHAEL BARBARO and REED ABELSON
Published: September 22, 2006
At first glance, Wal-Mart’s plan to sharply cut the cost of generic drugs, to $4, seems like a signal event in American health care. It could make scores of treatments affordable to the uninsured, reduce the burden on Medicaid and bring competitive pricing to the pharmacy industry.
Even company critics have praised the plan, conceding that it represents a case of the giant retailer using its size and ability to wring out costs to improve the lives of regular Americans.
But a close examination of the program, with details confirmed by the company yesterday, suggests that its impact could be blunted by several factors.
The plan, which is said to cover 300 drugs, includes only about 124 separate medicines in various dosages, like 12 versions of the popular antibiotic amoxicillin. It leaves out some popular drugs altogether, like the generic version of the cholesterol-lowering treatment Zocor.
Ron McCormick, manager of a Wal-Mart pharmacy in Tampa, Fla. The store and others in the area are the test market for the company’s lower-cost prescription plan for generic drugs
And while uninsured people should benefit from the program, those with insurance may save only a dollar or so, making a trip to Wal-Mart not worth their while, analysts said. In Florida, where the program will have its debut, most people on Medicaid pay nothing and may have little incentive to shop around for cheaper prescription drugs.
“It is not as significant as it first seems, in our opinion,” said Joseph Agnese, an analyst at Standard & Poor’s, who expressed surprise at investors’ reaction to the Wal-Mart announcement, which sent shares of its competitors CVS and Walgreen down sharply yesterday.
FULL 2 page story at link above.